News

NICE recommends appetite suppressing drug which can reduce a patient’s by more than 10%

Greater urgency for kidney cancer treatments as 40% of UK patients wait 84 days for a diagnosis

Extensive research into pharmacy responses across Europe during the pandemic yields several recommendations

Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes

UK’s health and social care secretary will declare war on cancer with a decade-long plan to combat disease misery

Pharma giant Sanofi continues to modernise with branding which reflects its commitment to social responsibility and sustainability

Significant landmark as NICE recommends AstraZeneca’s chronic kidney disease treatment Forxiga

Research collaboration between Parkinson’s UK and Domainex has potential to improve 140,000 lives

Boost for patients with life-threatening conditions who require access to medicines not yet authorised for marketing

Coalition urges reformation of EU-wide drug research and development to drive treatment optimisation

Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity

Ayvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis

Vulnerable people at risk from COVID-19 are set to have access to game-changing Pfizer antiviral

Positive news for children aged six to 11 as Dupixent offers improved asthma treatment

Gene luminaries Oxford Biomedica reach agreement with Homology Medicines to develop super group